Analystreport

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) is now covered by analysts at HC Wainwright. They set a "neutral" rating on the stock.

SUNESIS PHARMACEUTICALS  (SNSS) 
Last sunesis pharmaceuticals earnings: 3/10 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.sunesis.com/investor-overview